487 related articles for article (PubMed ID: 9087332)
1. Increased virulence of Marek's disease virus field isolates.
Witter RL
Avian Dis; 1997; 41(1):149-63. PubMed ID: 9087332
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
Calnek BW; Harris RW; Buscaglia C; Schat KA; Lucio B
Avian Dis; 1998; 42(1):124-32. PubMed ID: 9533089
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
4. Recent increase of Marek's disease in Korea related to the virulence increase of the virus.
Sung HW
Avian Dis; 2002; 46(3):517-24. PubMed ID: 12243513
[TBL] [Abstract][Full Text] [Related]
5. Pathotyping of Australian isolates of Marek's disease virus in commercial broiler chickens vaccinated with herpesvirus of turkeys (HVT) or bivalent (HVT/SB1) vaccine and association with viral load in the spleen and feather dander.
Walkden-Brown SW; Islam A; Islam AF; Burgess SK; Groves PJ; Cooke J
Aust Vet J; 2013 Aug; 91(8):341-50. PubMed ID: 23889101
[TBL] [Abstract][Full Text] [Related]
6. Coinfection of specific-pathogen-free chickens with Marek's disease virus (MDV) and chicken infectious anemia virus: effect of MDV pathotype.
Miles AM; Reddy SM; Morgan RW
Avian Dis; 2001; 45(1):9-18. PubMed ID: 11332504
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Marek's disease viruses isolated from vaccinated commercial chicken flocks: association of viral pathotype with lymphoma frequency.
Witter RL
Avian Dis; 1983; 27(1):113-32. PubMed ID: 6303287
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Marek's disease field isolates by the "best fit" pathotyping assay.
Dudnikova E; Norkina S; Vlasov A; Slobodchuk A; Lee LF; Witter RL
Avian Pathol; 2007 Apr; 36(2):135-43. PubMed ID: 17479374
[TBL] [Abstract][Full Text] [Related]
9. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
10. Examination of the effect of a naturally occurring mutation in glycoprotein L on Marek's disease virus pathogenesis.
Santin ER; Shamblin CE; Prigge JT; Arumugaswami V; Dienglewicz RL; Parcells MS
Avian Dis; 2006 Mar; 50(1):96-103. PubMed ID: 16617990
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
[TBL] [Abstract][Full Text] [Related]
12. Effect of serotype 2 and 3 Marek's disease vaccines on the development of avian leukosis virus-induced pre-neoplastic bursal follicles.
Marsh JD; Bacon LD; Fadly AM
Avian Dis; 1995; 39(4):743-51. PubMed ID: 8719208
[TBL] [Abstract][Full Text] [Related]
13. Pathotyping of recent Indian field isolates of Marek's disease virus serotype 1.
Suresh P; Johnson Rajeswar J; Sukumar K; Harikrishnan TJ; Srinivasan P
Acta Virol; 2015 Jun; 59(2):156-65. PubMed ID: 26104332
[TBL] [Abstract][Full Text] [Related]
14. Classification of Marek's disease viruses according to pathotype: philosophy and methodology.
Witter RL; Calnek BW; Buscaglia C; Gimeno IM; Schat KA
Avian Pathol; 2005 Apr; 34(2):75-90. PubMed ID: 16191686
[TBL] [Abstract][Full Text] [Related]
15. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
Nazerian K; Witter RL; Lee LF; Yanagida N
Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
[TBL] [Abstract][Full Text] [Related]
16. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
Calnek BW; Schat KA; Peckham MC; Fabricant J
Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
[TBL] [Abstract][Full Text] [Related]
17. Retroviral insertional mutagenesis of a herpesvirus: a Marek's disease virus mutant attenuated for oncogenicity but not for immunosuppression or in vivo replication.
Witter RL; Li D; Jones D; Lee LF; Kung HJ
Avian Dis; 1997; 41(2):407-21. PubMed ID: 9201407
[TBL] [Abstract][Full Text] [Related]
18. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
19. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
Sharma JM; Witter RL
Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
[TBL] [Abstract][Full Text] [Related]
20. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
Eidson CS
Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
